CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C01804 | BRD-A73741725 | exemestane | CYP19A1 | Aromatase inhibitor | -- | Details |
C01805 | BRD-A73747855 | BRD-A73747855 | -- | -- | -- | Details |
C01806 | BRD-A73847809 | BRD-A73847809 | -- | -- | -- | Details |
C01807 | BRD-A73859745 | BRD-A73859745 | -- | -- | glycodeoxycholic-acid | Details |
C01808 | BRD-A73908300 | EX-527 | SIRT1 | SIRT inhibitor | -- | Details |
C01809 | BRD-A73909368 | dactinomycin | POLR2A | RNA polymerase inhibitor | -- | Details |
C01810 | BRD-A73929928 | BRD-A73929928 | ADORA1 | Adenosine receptor agonist | -- | Details |
C01811 | BRD-A73965025 | BRD-A73965025 | -- | -- | -- | Details |
C01812 | BRD-A73972952 | BG-1010 | -- | -- | -- | Details |
C01813 | BRD-A74134989 | BRD-A74134989 | -- | -- | -- | Details |
C01814 | BRD-A74152721 | BRD-A74152721 | -- | -- | -- | Details |
C01815 | BRD-A74160776 | troxerutin | -- | -- | -- | Details |
C01816 | BRD-A74269027 | isoxsuprine | ADRB2 | Adrenergic receptor agonist | -- | Details |
C01817 | BRD-A74382794 | BRD-A74382794 | -- | -- | -- | Details |
C01818 | BRD-A74391928 | ibutilide | KCNH2; CACNA1C | Potassium channel blocker | -- | Details |
C01819 | BRD-A74500471 | ethambutol | -- | -- | -- | Details |
C01820 | BRD-A74608937 | BRD-A74608937 | -- | -- | -- | Details |
C01821 | BRD-A74615450 | BRD-A74615450 | -- | -- | -- | Details |
C01822 | BRD-A74642112 | rathyronine | -- | -- | -- | Details |
C01823 | BRD-A74667430 | etodolac | PTGS2 | Cyclooxygenase inhibitor | -- | Details |
C01824 | BRD-A74699940 | BRD-A74699940 | -- | -- | -- | Details |
C01825 | BRD-A74767450 | BRD-A74767450 | -- | -- | -- | Details |
C01826 | BRD-A74771556 | nikkomycin | -- | -- | -- | Details |
C01827 | BRD-A74904029 | EI-231 | CSNK2A1 | Casein kinase inhibitor | -- | Details |
C01828 | BRD-A74907996 | equol | ESR1; ESR2 | Estrogen receptor agonist | -- | Details |
C01829 | BRD-A74914197 | pralatrexate | DHFR | Dihydrofolate reductase inhibitor | -- | Details |
C01830 | BRD-A74975734 | homatropine | CHRM1 | Acetylcholine receptor antagonist | -- | Details |
C01831 | BRD-A74980173 | gatifloxacin | -- | -- | -- | Details |
C01832 | BRD-A74983348 | BRD-A74983348 | -- | -- | -- | Details |
C01833 | BRD-A75087829 | BRD-A75087829 | -- | -- | -- | Details |
C01834 | BRD-A75106577 | BRD-A75106577 | -- | -- | -- | Details |
C01835 | BRD-A75140635 | salsolidine | -- | -- | -- | Details |
C01836 | BRD-A75144621 | digoxin | ATP1A1 | ATPase inhibitor | -- | Details |
C01837 | BRD-A75172220 | hydrocortisone | NR3C1 | Glucocorticoid receptor agonist | -- | Details |
C01838 | BRD-A75224450 | ibuprofen-piconol | PTGS1; PTGS2 | Cyclooxygenase inhibitor | -- | Details |
C01839 | BRD-A75301702 | BRD-A75301702 | -- | -- | -- | Details |
C01840 | BRD-A75305484 | anidulafungin | -- | -- | -- | Details |
C01841 | BRD-A75368507 | demeclocycline | -- | -- | -- | Details |
C01842 | BRD-A75402480 | deoxycorticosterone-acetate | -- | -- | -- | Details |
C01843 | BRD-A75409952 | wortmannin | PIK3CA; PIK3CG; PLK1 | PI3K inhibitor | -- | Details |
C01844 | BRD-A75421526 | BRD-A75421526 | -- | -- | -- | Details |
C01845 | BRD-A75455249 | kavain | MTOR | Sodium channel blocker; Calcium channel modulator | -- | Details |
C01846 | BRD-A75471153 | BRD-A75471153 | -- | -- | -- | Details |
C01847 | BRD-A75478957 | PD-166793 | MMP2; MMP3; MMP13 | Collagenase inhibitor; Metalloproteinase inhibitor | -- | Details |
C01848 | BRD-A75479906 | rimantadine | -- | -- | -- | Details |
C01849 | BRD-A75517195 | thiazolopyrimidine | -- | -- | -- | Details |
C01850 | BRD-A75552914 | isoxicam | PTGS1; PTGS2 | Cyclooxygenase inhibitor | -- | Details |
C01851 | BRD-A75558199 | BRD-A75558199 | -- | -- | -- | Details |
C01852 | BRD-A75607876 | BRD-A75607876 | -- | -- | -- | Details |
C01853 | BRD-A75726477 | clenbuterol | ADRB2 | Adrenergic receptor agonist | -- | Details |
C01854 | BRD-A75769826 | SDM-25N | OPRD1 | Opioid receptor antagonist | -- | Details |
C01855 | BRD-A75769921 | BRD-A75769921 | -- | -- | -- | Details |
C01856 | BRD-A75771022 | BRD-A75771022 | -- | -- | -- | Details |
C01857 | BRD-A75817871 | blebbistatin | MYH2 | ATPase inhibitor | -- | Details |
C01858 | BRD-A75850590 | lomefloxacin | -- | -- | -- | Details |
C01859 | BRD-A75919782 | leucovorin | -- | -- | -- | Details |
C01860 | BRD-A75931230 | F-1061-0166 | -- | -- | -- | Details |
C01861 | BRD-A75935363 | atracurium | -- | -- | -- | Details |
C01862 | BRD-A75954196 | BRD-A75954196 | -- | -- | -- | Details |
C01863 | BRD-A75976779 | BRD-A75976779 | -- | -- | -- | Details |
C01864 | BRD-A76019558 | ketoconazole | CYP19A1; AR | Sterol demethylase inhibitor | -- | Details |
C01865 | BRD-A76076412 | BRD-A76076412 | -- | -- | -- | Details |
C01866 | BRD-A76093993 | cromakalim | KCNJ8 | Potassium channel activator | -- | Details |
C01867 | BRD-A76229785 | lymecycline | -- | -- | -- | Details |
C01868 | BRD-A76279427 | myriocin | -- | -- | -- | Details |
C01869 | BRD-A76463343 | VU-0447134-2 | -- | -- | -- | Details |
C01870 | BRD-A76490030 | K784-3131 | -- | -- | K-784-3131 | Details |
C01871 | BRD-A76528577 | vincristine | TUBB | Tubulin inhibitor | -- | Details |
C01872 | BRD-A76641868 | BRD-A76641868 | -- | -- | STOCK-4S-27438 | Details |
C01873 | BRD-A76680315 | 650_0048_7570 | -- | -- | -- | Details |
C01874 | BRD-A76732176 | BRD-A76732176 | -- | -- | -- | Details |
C01875 | BRD-A76746748 | cefuroxime | -- | -- | -- | Details |
C01876 | BRD-A76747559 | rutin | AKR1C3 | Antioxidant; Nitric oxide scavenger; Capillary stabilizing agent | -- | Details |
C01877 | BRD-A76899420 | BRD-A76899420 | -- | -- | -- | Details |
C01878 | BRD-A76904477 | BRD-A76904477 | -- | -- | -- | Details |
C01879 | BRD-A76905089 | BRD-A76905089 | -- | -- | -- | Details |
C01880 | BRD-A76934284 | BRD-A76934284 | -- | -- | (+)-3-(1-propyl-piperidin-3-yl)-phenol | Details |
C01881 | BRD-A76941896 | doxorubicin | TOP2A | Topoisomerase inhibitor | -- | Details |
C01882 | BRD-A77050075 | heraclenol | -- | -- | -- | Details |
C01883 | BRD-A77065707 | BRD-A77065707 | -- | -- | -- | Details |
C01884 | BRD-A77098556 | BRD-A77098556 | -- | -- | -- | Details |
C01885 | BRD-A77118605 | D-609 | -- | -- | BML-ST330 | Details |
C01886 | BRD-A77144340 | ketocholesterol | -- | -- | -- | Details |
C01887 | BRD-A77164655 | BRD-A77164655 | -- | -- | -- | Details |
C01888 | BRD-A77181042 | BRD-A77181042 | -- | -- | -- | Details |
C01889 | BRD-A77216878 | manumycin-a | FNTA; IKBKB | NFKB pathway inhibitor; Farnesyltransferase inhibitor | -- | Details |
C01890 | BRD-A77218119 | SYM-2206 | GRIA1; GRIA2; GRIA3; GRIA4 | Glutamate receptor antagonist | -- | Details |
C01891 | BRD-A77291778 | cyclopentolate | -- | -- | -- | Details |
C01892 | BRD-A77292814 | BRD-A77292814 | -- | -- | -- | Details |
C01893 | BRD-A77299732 | salubrinal | EIF2S1 | Eukaryotic translation initiation factor inhibitor | -- | Details |
C01894 | BRD-A77328124 | MW-RAS14 | -- | -- | -- | Details |
C01895 | BRD-A77328129 | BRD-A77328129 | -- | -- | -- | Details |
C01896 | BRD-A77349281 | RK-682 | -- | -- | -- | Details |
C01897 | BRD-A77414132 | emetine-hcl | -- | -- | -- | Details |
C01898 | BRD-A77440546 | BRD-A77440546 | -- | -- | -- | Details |
C01899 | BRD-A77467113 | EMF-sumo1-11 | -- | -- | -- | Details |
C01900 | BRD-A77488069 | BRD-A77488069 | -- | -- | -- | Details |
C01901 | BRD-A77577770 | BRD-A77577770 | -- | -- | palmitoylcarnitine | Details |
C01902 | BRD-A77697958 | BRD-A77697958 | -- | -- | -- | Details |
C01903 | BRD-A77704559 | BRD-A77704559 | -- | -- | -- | Details |